Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nami Shirakawa"'
Autor:
Takanori Fukuta, Takashi Tanaka, Taiki Hashimoto, Kenji Isahaya, Yuko Kubo, Yoshihisa Yamano, Kaishi Satomi, Nobuyoshi Hiraoka, Nami Shirakawa, Ayumu Arakawa, Chitose Ogawa, Nao Nishimura, Jun Aoki, Ayumu Ito, Yoshihiro Inamoto, Sung-Won Kim, Takahiro Fukuda
Publikováno v:
International Journal of Hematology. 117:933-940
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a48dcd667cc014273867ad9a6942c0df
https://doi.org/10.1007/s12185-023-03539-5
https://doi.org/10.1007/s12185-023-03539-5
Autor:
Masanaka Sugiyama, Ayumu Arakawa, Nami Shirakawa, Kayoko Tao, Kazuki Tanimura, Miho Nakajima, Yuko Watanabe, Tadashi Kumamoto, Junnosuke Maniwa, Akihiro Yoneda, Shintaro Iwata, Eisuke Kobayashi, Akira Kawai, Chitose Ogawa
Publikováno v:
Pediatric Blood & Cancer. 70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ba36ff7ac1cbb3dd9b84d52b04e0763
https://doi.org/10.1002/pbc.30360
https://doi.org/10.1002/pbc.30360
Autor:
Kazuki Tanimura, Miho Nakajima, Nami Shirakawa, Kayoko Tao, Masanaka Sugiyama, Yuko Watanabe, Ayumu Arakawa, Miyu Kikuchi, Masamichi Takahashi, Yoshitaka Narita, Mika Shiotsuka, Osamu Kobayashi, Satoshi Iwata, Akihiko Yoshida, Masahiro Abe, Satoshi Yamagoe, Yoshitsugu Miyazaki, Chitose Ogawa
Publikováno v:
Pediatric Blood & Cancer. 70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3fc7f83e5d089bc7d30baff3c5c3b01
https://doi.org/10.1002/pbc.30049
https://doi.org/10.1002/pbc.30049
Autor:
Masanaka Sugiyama, Ayumu Arakawa, Yasunori Kogure, Nami Shirakawa, Mizuki Watanabe, Yuta Ito, Kazuki Tanimura, Kayoko Tao, Miho Nakajima, Yuko Watanabe, Akiko Miyagi-Maeshima, Suguru Fukuhara, Keisuke Kataoka, Koji Izutsu, Takahiro Fukuda, Chitose Ogawa
Publikováno v:
Pediatric Blood & Cancer; Jan2024, Vol. 71 Issue 1, p1-3, 3p
Autor:
Takanori Fukuta, Takashi Tanaka, Taiki Hashimoto, Kenji Isahaya, Yuko Kubo, Yoshihisa Yamano, Kaishi Satomi, Nobuyoshi Hiraoka, Nami Shirakawa, Ayumu Arakawa, Chitose Ogawa, Nao Nishimura, Jun Aoki, Ayumu Ito, Yoshihiro Inamoto, Sung-Won Kim, Takahiro Fukuda
Background: Nelarabine is an effective treatment for T-cell acute lymphoblastic leukemia/lymphoma. Myelopathy is a problematic adverse event associated with nelarabine. The mechanism leading to myelopathy is unclear. Diagnostic methods and therapy fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::921d4045f420fd8bad0f300258f83393
https://doi.org/10.21203/rs.3.rs-1643949/v1
https://doi.org/10.21203/rs.3.rs-1643949/v1
Autor:
Yasuaki Arai, K Shimada, Shunsuke Sugawara, Chitose Ogawa, Ayumu Arakawa, Naonori Kawakubo, Miyuki Sone, Nami Shirakawa, Tomoro Hishiki
Publikováno v:
International Journal of Surgery Oncology. 5:e981-e984
Rationale: Unresectable abdominal tumors cause various complications, and fistulizaton with intestine is a rare but serious complication. We report this condition in 2 cases. Patient Concerns: The first case was that of a 14-year-old male patient who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e8c78b4570b97f784850e31d38bb14e
https://doi.org/10.1097/ij9.0000000000000098
https://doi.org/10.1097/ij9.0000000000000098
Autor:
Hironobu Hashimoto, Chitose Ogawa, Yoshimasa Saito, Tomoko Sonoda, Masakazu Yamaguchi, Ayumu Arakawa, Yoshinori Makino, Miho Nakajima, Masanaka Sugiyama, Nami Shirakawa, Sae Ishimaru, Takamichi Arima, Tadashi Kumamoto
Publikováno v:
Pediatrics International. 61:235-239
Background Single-dose i.v. fosaprepitant has been approved as an alternative to 3 day oral aprepitant, a neurokinin-1 receptor antagonist, and improves prevention of chemotherapy-induced nausea and vomiting (CINV). Because fosaprepitant has shown si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aaa9ad01cdbef7c6822de3a76cebfbe
https://doi.org/10.1111/ped.13780
https://doi.org/10.1111/ped.13780
Autor:
Miho Maeda, Miho Yamanishi, Chitose Ogawa, Tomoko Sonoda, Akiko Miyagi Maeshima, Ayumu Arakawa, Nami Shirakawa, Yoshimasa Saito, Sae Ishimaru, Tadashi Kumamoto, Yuki Aoki, Masanaka Sugiyama
Publikováno v:
International Journal of Hematology. 109:228-232
Histiocytic sarcoma in advanced clinical stages is typically an aggressive neoplasm, with poor response to conventional chemotherapy. An 18-year-old male with refractory histiocytic sarcoma that had transformed from Rosai-Dorfman disease was admitted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60ce8c10e03c50a737e20fa5c5bd203e
https://doi.org/10.1007/s12185-018-2553-9
https://doi.org/10.1007/s12185-018-2553-9